U.S. approves gene therapy treatment for hemophilia

26 avril 2024 | Agence France-Presse
Pharmaceutical giant Pfizer has received U.S. approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the company said Friday. Beqvez, which is given as a single intravenous infusion, was shown in a clinical trial of 45 people to be better at (...)
 Site référencé:  Raw Story

Raw Story 

Jim Jordan again pushes DOJ to charge 'liar' Michael Cohen over Trump prosecution
8/05/2024
'Most transparent president' Trump won't meet financial transparency deadline. Again.
8/05/2024
77% of top climate scientists think 2.5°C of warming is coming—and they're horrified
8/05/2024
Ivanka shares 'cryptic' poem as Trump faces off against Stormy Daniels in court : report
8/05/2024
'They dug a hole with golden shovels' : Biden slams Trump for failed Foxconn 'con' deal
8/05/2024
Trump spends court-free day hanging with trading card fans instead of campaigning : report
8/05/2024